Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Apo-Furosemide

This product is the most expensive of its product family


Not recommended
Impairment the perfusion of the placenta and therefore intrauterine growth

Contraindicated
Furosemide inhibits lactation
Apo-Furosemide :
Type Medicine Authorised
Originator Lasix Tablets 40mg
Agent Promopharm
Distributor Promopharm
Laboratory Apotex
Responsible Party Apotex Inc
Origin Canada
Manufacturer Apotex Inc
Manufacturing Type G
Origin Canada
ATC C03CA01

Your comment will appear shortly after approval

Apo-Furosemide :

Revision Date : 01/09/2016


Effect Frequency
Acute generalised exanthematous pustulosis (AGEP) Not known
Agranulocytosis Very rare
Anaphylactic reactions Rare
Anaphylactoid reactions Rare
Aplastic anemia Very rare
Blackout (Blacked-out) Not known
Blood cholesterol increased Common
Blood creatinine increased Very Common
Blood triglycerides increased Very Common
Blood urea increased Not known
Blood uric acid increased Common
Bullous pemphigoid Uncommon
Cholestasis Very rare
Deafness Uncommon
Dehydration Very Common
Dermatitis bullous Uncommon
Dermatitis exfoliative Uncommon
Diarrhoea (Diarrhea) Rare
DRESS (Drug reaction with eosinophilia and systemic symptoms) Not known
Eosinophilia Rare
Erythema multiforme minor Uncommon
Fever Rare
Fluid and electrolyte imbalance Very Common
Glucose tolerance decreased Uncommon
Gout attack/Gout flare Common
Haemoconcentration Common
Haemolytic anemia Very rare
Hearing impaired Uncommon
Hepatic encephalopathy Common
Hypocalcaemia Not known
Hypochloraemia Common
Hypokalaemia Common
Hypomagnesaemia Not known
Hyponatraemia (Hyponatremia) Common
Hypovolaemia (Volume depletion) (Hypovolemia) Very Common
Injection site pain Not known
Interstitial nephritis Rare
Jaundice Very rare
Leucopenia (Leukopenia) Rare
Loss of consciousness Not known
Lyell Syndrome (Toxic epidermal necrolysis) Not known
Metabolic alkalosis Not known
Nausea Uncommon
Pancreatitis acute Very rare
Paraesthesia (paresthesia) Rare
Patent ductus arteriosus Not known
Photosensitivity Uncommon
Pruritus Uncommon
Pseudo-Bartter syndrome Not known
Purpura Uncommon
Renal failure Not known
Shock Rare
Skin rash Uncommon
Stevens-Johnson syndrome Not known
Systemic lupus erythematosus Not known
Thrombocytopenia (Thrombopenia) Uncommon
Thrombosis Common
Tinnitus Very rare
Transaminases increased Very rare
Urine chloride increased Not known
Urine output increased Common
Urine sodium increased Not known
Urticaria Uncommon
Vasculitis Rare
Vertigo Not known
Vomiting Rare

Different Units By MoH Code

Revision Date : 13/07/2018

Revision Date : 13/07/2018

Apo-Furosemide  MoH 988 :
Form Tablet
Packaging Bottle
Package Size Box of 100
Strength 40mg
Public Price 862746.88 L.L.
Stratum A2
NSSF ✔
Quarantine ✘
Reg. Number MP MO 581/91
Submission date 01/01/1991
Registration Year 1992
Barcode 771313003810


Price Comparison

● Country: Lebanon
● Form: Tablet
● Package Size: Box of 100
● Public Price: 862746.88 LBP ( 862,746.88 LBP )
● Pack size unit used: 100
● Cost/Unit: 8627,47 LBP ( 8,627.00 LBP )
● Pricing Date: 13/06/2024

● Country: Spain
● Package Size: 30
● Public Price: 2.25 EUR ( 217,971.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 0,075 EUR ( 0.00 LBP )
● Pharmacy Price: 1.44 EUR ( 139501.44 LBP )
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Non Marketed

● Country: New Zealand
● Package Size: 1000 tab
● Exfactory Price: 7.24 NZD
● Reference: New Zealand Pharmaceutical Management Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info